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ABSTRACT The Saccharomyces cerevisiae protein kinase Sch9 is an in vitro and in vivo effec-
tor of sphingolipid signaling. This study examines the link between Sch9 and sphingolipid 
metabolism in S. cerevisiae in vivo based on the observation that the sch9Δ mutant displays 
altered sensitivity to different inhibitors of sphingolipid metabolism, namely myriocin and 
aureobasidin A. Sphingolipid profiling indicates that sch9Δ cells have increased levels of long-
chain bases and long-chain base-1 phosphates, decreased levels of several species of (phyto)
ceramides, and altered ratios of complex sphingolipids. We show that the target of rapamy-
cin complex 1–Sch9 signaling pathway functions to repress the expression of the ceramidase 
genes YDC1 and YPC1, thereby revealing, for the first time in yeast, a nutrient-dependent 
transcriptional mechanism involved in the regulation of sphingolipid metabolism. In addition, 
we establish that Sch9 affects the activity of the inositol phosphosphingolipid phospholipase 
C, Isc1, which is required for ceramide production by hydrolysis of complex sphingolipids. 
Given that sphingolipid metabolites play a crucial role in the regulation of stress tolerance 
and longevity of yeast cells, our data provide a model in which Sch9 regulates the latter phe-
notypes by acting not only as an effector but also as a regulator of sphingolipid metabolism.
INTRODUCTION
Sphingolipids, together with sterols and glycerophospholipids, are 
essential components of all eukaryotic membranes. Much of the 
progress in the understanding of sphingolipid metabolism is due to 
research performed in the budding yeast Saccharomyces cerevisiae, 
in which most, if not all, of the enzymes involved in sphingolipid 
metabolism have been identified (Figure 1; Funato et al., 2002; Sims 
et al., 2004; Dickson et al., 2006). Apart from their structural func-
tion, sphingolipids also play important regulatory roles. More spe-
cifically, in yeast, sphingolipids are involved in the regulation of cel-
lular processes as diverse as cell growth, endocytosis, actin 
cytoskeleton organization, protein trafficking, cell wall integrity, nu-
trient uptake, and longevity (Dickson, 2010). In these processes, sig-
naling functions are ascribed not only to the complex sphingolipid 
species, but also to the intermediate metabolites, that is, the long-
chain bases (LCBs), the long-chain base 1-phosphates (LCBPs), and 
ceramide species. Accumulating evidence in yeast and mammalian 
model systems strongly suggests that the dynamic balance between 
the different sphingolipid metabolites, often referred to as the 
LCB(P)/ceramide rheostat or sphingolipid rheostat, is an important 
factor determining their regulatory action (Kobayashi and Nagiec, 
2003; Kihara et al., 2007; Dickson, 2008; Matmati and Hannun, 
2008; Breslow and Weissman, 2010; Bikman and Summers, 2011; 
Van Brocklyn and Williams, 2012). As such, proper regulation of this 
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rapamycin-sensitive, nutrient-responsive TORC1 kinase, recent evi-
dence shows that these phosphorylation sites are distinct from those 
regulated by myriocin treatment, indicating that TORC1 and TORC2 
have distinct roles in the control of the Orm proteins (Liu et al., 2012; 
Shimobayashi et al., 2013). Indeed, rapamycin-induced phosphory-
lation of Orm1/2 did not seem to affect SPT activity. Instead, a stim-
ulation of complex sphingolipid synthesis was observed, through 
as-yet-unknown mechanisms. Additional evidence for a nutrient-
dependent regulation of complex sphingolipid levels comes from a 
recent lipidomic approach, in which it was shown that relative levels 
of different complex sphingolipid species change as yeast cells en-
ter the stationary phase (Klose et al., 2012).
To help coordinate cellular responses to changing nutrient levels, 
yeast depends on Sch9, a protein kinase with a central role in the 
carbon and nitrogen source–dependent signaling pathway that con-
trols cell growth, longevity, and stress resistance (Toda et al., 1988; 
Crauwels et al., 1997; Fabrizio et al., 2001; Roosen et al., 2005; 
Smets et al., 2008, 2010). Sch9 performs this function, in part, by 
acting as an effector of the TORC1 complex (Urban et al., 2007), al-
though several studies indicated that Sch9 also acts independently 
of TORC1 (Yorimitsu et al., 2007; Smets et al., 2008). Like Ypk1/2, 
Sch9 can be phosphorylated by Pkh1 and Pkh2 at its PDK1 site in its 
activation loop, and this phosphorylation is indispensable for its 
function (Roelants et al., 2004; Urban et al., 2007; Voordeckers et al., 
balance is key to cellular survival, and recent reports have shed 
some light on the molecular mechanisms by which yeast controls 
this balance. For instance, the yeast Orm1 and Orm2 proteins are 
crucial regulators of sphingolipid homeostasis by controlling the ac-
tivity of the serine palmitoyl transferase (SPT) enzyme, which cata-
lyzes the first and rate-limiting step in de novo synthesis of sphingo-
lipids. Orm1/2 are members of the conserved ORMDL family of 
endoplasmic reticulum (ER) membrane proteins (ORMDL 1/2/3 
genes in humans) and physically interact with SPT, inhibiting the 
activity of the enzyme (Breslow et al., 2010; Han et al., 2010). This 
inhibitory action is abrogated through Orm1/2 phosphorylation by 
the protein kinase Ypk1 (Roelants et al., 2011). When sphingolipid 
levels drop—for example, when cells are treated with the SPT inhibi-
tor myriocin—the target of rapamycin complex 2 (TORC2) kinase 
activates Ypk1, boosting de novo sphingolipid synthesis to counter-
act dropping sphingolipid levels. In addition, the increase in LCB 
accumulation on heat shock is also dependent on Ypk1’s action, 
downstream of the Pkh1/2 kinases (Sun et al., 2012).
Interestingly, as yeast cells approach stationary phase, they ac-
cumulate LCBs and LCBPs as well (Lester et al., 2013). This increase 
may also be mediated in part by an increase in SPT activity, although 
additional mechanisms, such as a decrease in ceramide synthase 
activity as cells enter the stationary phase, were also demonstrated. 
Although phosphorylation of the Orm proteins depends on the 
FIGURE 1: Schematic representation of sphingolipid biosynthesis (adapted from Dickson, 2008). A schematic 
representation of the de novo biosynthesis pathway for sphingolipids, with the genes encoding for the involved 
enzymes in italic and both the complex sphingolipids and the different intermediates of sphingolipid biosynthesis in 
bold. Used inhibitors of sphingolipid biosynthesis are shown. Changes in sphingolipid profile for the sch9Δ strain, 
compared with the WT strain, are indicated with closed arrows for LCB and ceramide species (see Figure 3 for results) 
and open arrows for complex sphingolipids (see Figure 7 for results).
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of low concentrations of PHS rescues myriocin toxicity (Sun et al., 
2000), whereas addition of high concentrations of PHS inhibits cell 
growth (Ella et al., 1997; Skrzypek et al., 1998; Chung et al., 2001). 
Analysis of the growth of sch9Δ mutant and WT cells in the pres-
ence of different concentrations of PHS revealed that sch9Δ mutant 
cells are more sensitive to the growth-inhibitory effect of PHS than 
WT cells (Figure 2E), suggesting that cells lacking Sch9 already 
have higher internal pools of LCBs and LCBPs. In line with this are 
the data obtained upon monitoring the effect of the fungicide au-
reobasidin A. This fungicide inhibits Aur1 (Figure 1), an enzyme 
responsible for the production of the complex sphingolipid inosi-
tolphosphoryl ceramide (IPC; Heidler and Radding, 1995). The tox-
icity of aureobasidin A is due not only to the inhibition of the syn-
thesis of complex sphingolipids, but also to the accumulation of 
LCBs (Nagiec et al., 1997). Consistently, we observed that the 
sch9Δ mutant was more sensitive to aureobasidin A than the WT 
strain (Figure 2F).
Deletion of SCH9 alters the LCB(P)/ceramide balance
To evaluate the hypothesis that cells lacking Sch9 have higher lev-
els of intermediary sphingolipid metabolites and thus that Sch9 
may function as modulator of sphingolipid metabolism in vivo, we 
determined the levels of PHS and dihydrosphingosine (DHS), their 
phosphates, phytosphingosine-1-phosphate (PHS-P) and dihy-
drosphingosine-1-phosphate (DHS-P), and the levels of (phyto)cer-
amides in the membranes of the WT and the sch9Δ strain. Com-
pared to the WT strain, sch9Δ cells were characterized by increased 
levels of DHS, PHS, and PHS-P, whereas levels of DHS-P remained 
below the detection limit (Figure 3A). Conversely, the concentra-
tions of the ceramides C18-dihydroceramide, C20-dihydroceramide, 
and C26-phytoceramide were decreased in sch9Δ cells (Figure 3, B 
and C), as was the amount of α-hydroxylated phytoceramide (αOH-
PhytoCer-C26; Figure 3D). Thus, these data suggest that the Sch9 
protein kinase fulfils a regulatory role to maintain de novo ceramide 
synthesis.
An increase of LCB(P)s in sch9Δ cells could be the result of an 
increase in SPT activity, perhaps through phosphorylation of the 
Orm proteins. However, in this case we would expect that also cer-
amide levels would have increased, as shown before for the orm1Δ 
orm2Δ strain (Breslow et al., 2010; Shimobayashi et al., 2013). Alter-
natively, Sch9 could also be involved in very long-chain fatty acid 
formation, which serves as a substrate in the ceramide production 
(Figure 1). As such, the LCB(P)s may accumulate due to the inability 
to react with very long-chain fatty acids to form ceramides, as is the 
case in sur4Δ cells (Breslow et al., 2010). However, we present ge-
netic evidence that SCH9 and SUR4 work in parallel pathways, mak-
ing this possibility unlikely (Supplemental Figure S1, B and C). 
Therefore a more obvious explanation is that Sch9 plays a role at 
the step of ceramide production or breakdown. This is supported by 
our genetic data showing that deletion of either gene encoding ce-
ramidase (YDC1 or YPC1) abrogates myriocin resistance of the 
sch9Δ strain (Supplemental Figure S1A), as does overexpression of 
the ceramide synthase LAG1 or LAC1 (Supplemental Figure S1D). 
To have a closer look at the enzymes involved in ceramide produc-
tion and breakdown, we constructed WT and sch9Δ strains express-
ing chromosomally encoded, Myc-tagged versions of Lag1, Lac1, 
Ydc1, and Ypc1 and analyzed their protein levels. We included the 
addition of rapamycin in these experiments, as this compound is 
well known for its ability to inactivate TORC1, a major nutrient-de-
pendent activator of Sch9 (Urban et al., 2007). Results in Figure 4 
indicate that either deleting SCH9 or treating WT cells with rapamy-
cin increases the presence of the ceramidases Ydc1 and Ypc1. 
2011). In line with the suggested activation of Pkh1/2 by the long-
chain base phytosphingosine (PHS), the phosphorylation and activa-
tion of Sch9 by Pkh1 is enhanced in vitro by the addition of PHS (Liu 
et al., 2005) and lowered in vivo by pharmacological or genetic re-
duction of sphingolipid synthesis (Huang et al., 2012; Liu et al., 
2013). Hence these results indicate that Sch9 is an effector of sphin-
golipid signaling.
In this study, we examine the link between Sch9 and sphingolipid 
metabolism in more detail. Our data demonstrate that Sch9 has a 
regulatory role in de novo ceramide biosynthesis and ceramide pro-
duction by hydrolysis of complex sphingolipids. We provide evi-
dence for a transcriptional regulatory mechanism in which Sch9 is 
required to repress ceramidase activity during growth by acting 
downstream of the TORC1 kinase. In addition, for hydrolytic cer-
amide production, Sch9 is essential for the proper translocation of 
the inositol phosphospingolipid phospholipase C, Isc1, from the ER 
to mitochondria during the diauxic shift. As such, Sch9 appears to 
be the gatekeeper of a monitoring system required to balance bio-
synthetic and hydrolytic ceramide production. We illustrate and dis-
cuss some of the phenotypic repercussions associated with this role 
of Sch9, focusing on mitochondrial activity, oxidative stress, aging, 
and longevity. Given the function of Sch9 in nutrient signaling and 
the fact that sphingolipids mediate Pkh-dependent phosphorylation 
and activation of Sch9, one obvious conclusion is that Sch9 is part of 
a feedback system balancing the sphingolipid rheostat in response 
to both internal sphingolipid signals and nutrient availability.
RESULTS
Deletion of SCH9 confers resistance to myriocin 
and increases sensitivity to aureobasidin A 
and phytosphingosine
To investigate the potential relationship between Sch9 and sphin-
golipid mediated signaling, we compared myriocin resistance of 
wild-type (WT) cells and isogenic sch9Δ mutants. Myriocin is an in-
hibitor of serine palmitoyl transferase (Figure 1), the primary enzyme 
in sphingolipid biosynthesis, encoded by LCB1, LCB2, and TSC3 
(Miyake et al., 1995; Sun et al., 2000). The analysis was performed 
in two genetic backgrounds, W303-1A and BY4741, to ensure that 
the observed effects were not related to the background used. The 
analysis also compared the use of different selection markers to cre-
ate the deletion of SCH9 in order to exclude possible marker ef-
fects. In all cases we found that cells lacking Sch9 displayed an in-
creased myriocin resistance, as visualized by spot assays (Figure 
2A). Overexpression of SCH9 in the sch9Δ mutant restored myriocin 
sensitivity (Figure 2B), indicating that the presence or absence of a 
functional Sch9 is the only factor that contributes to the observed 
differences in myriocin resistance. To evaluate whether increased 
myriocin resistance reflects increased survival, we performed a pro-
pidium iodide (PI) staining on WT cells and sch9Δ cells treated with 
0.5 μg/ml myriocin. As shown in Figure 2C, the viability of sch9Δ 
cells was hardly affected by myriocin treatment (0.7 ± 0.3% dead 
cells), whereas that of WT cells was markedly decreased (23.8 ± 
3.4% dead cells). Next we examined the effect of myriocin on the 
expression of ribosomal protein genes. Expression of these genes is 
tightly coupled to growth conditions, as they are induced under fa-
vorable conditions but repressed under adverse conditions. As ex-
pected, myriocin treatment triggered a significant decrease of ribo-
somal protein gene expression in WT cells, but had no effect in 
sch9Δ cells (Figure 2D).
We then investigated the sensitivity of WT and sch9Δ cells to 
PHS. Maintaining the balance in intermediary sphingolipid metab-
olites is of utmost importance for cell growth and survival. Addition 
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TORC1. On the other hand, mutation of these sites to aspartic (D) or 
glutamic (E) acid (SCH92D3E) results in the expression of a variant of 
Sch9 that mimics a constitutively phosphorylated, and therefore ac-
tive, Sch9, which cannot be inactivated by rapamycin treatment 
(Urban et al., 2007). We subcloned these SCH9 variants, along with 
the wild-type SCH9 gene, into the pRS415 vector to allow for coex-
pression with our YDC1- and YPC1-lacZ constructs in the sch9Δ 
strain. As shown in Figure 6, coexpression of the ceramidase lacZ 
constructs with wild-type SCH9 in the sch9Δ strain can complement 
the high basal lacZ activity observed with the empty vector (pRS415), 
as well as restore rapamycin induction of promoter activity. Further-
more, expressing the inactive SCH95A variant mimics the empty vec-
tor situation, demonstrating that phosphorylation of Sch9 by TORC1 
is required for keeping basal promoter activities in check. Further 
induction by rapamycin is also abolished in cells expressing this 
SCH95A construct. Expressing the phospho-mimic SCH92D3E variant, 
on the other hand, results in basal promoter activities, comparable 
to those observed when expressing the wild-type SCH9 gene 
(Figure 6). They are somewhat elevated compared with the wild-
type gene, likely due to the slight differences in in vivo conformation 
between the phospho-mimic and truly phosphorylated Sch9. Still, 
comparing basal promoter activities of cells expressing SCH95A and 
SCH92D3E clearly demonstrates the importance of phosphorylation 
of the TORC1-dependent residues of Sch9 in regulating ceramidase 
promoter activity. Intriguingly, rapamycin-mediated induction of 
YDC1- and YPC1-lacZ activity is completely lost in cells expressing 
the SCH92D3E variant, indicating that this induction by rapamycin 
requires a loss in phosphorylation of Sch9 by TORC1. Also, these 
results argue against additional effectors besides Sch9 in mediating 
the rapamycin effect.
In conclusion, due to the tight correlation between the effects 
observed in the lacZ experiments and the determination of protein 
levels (summarized in Table 1), our results point to the existence of a 
nutrient-dependent transcriptional response in which the TORC1–
Sch9 signaling pathway acts to repress the expression of the cerami-
dase enzymes (YDC1 and YPC1). In addition, TORC1-independent 
regulation mechanisms exist that affect the transcriptional regula-
tion of the genes encoding the ceramide synthases (LAG1 and 
LAC1), thereby constituting an independent homeostatic mecha-
nism controlling sphingolipid balance. Whether the latter mecha-
nism is also independent of Sch9 remains to be established. Indeed, 
despite being a major downstream effector of TORC1, Sch9 also 
performs functions independent of this upstream regulator (Pascual-
Ahuir and Proft, 2007; Smets et al., 2008).
Sch9 has a regulatory role in the metabolism of complex 
sphingolipids
Because Sch9 proved to have a significant effect on the LCB(P)/
ceramide balance, we set out to test how the complex sphingolipid 
profile was affected by deletion of SCH9. To this end, we measured 
the levels of the three major inositol phosphosphingolipid classes, 
namely IPC, mannosylinositolphosphoryl ceramide (MIPC), and 
mannosyldiinositolphosphoryl ceramide (M(IP)2C), in membranes of 
WT and sch9Δ cells. This revealed that the sch9Δ mutant combined 
relative reduced levels of IPC with increased levels of MIPC and 
M(IP)2C (Figure 7). Intriguingly, a recent lipidomic approach indi-
cated that as yeast cells go into the stationary phase, IPC levels 
drop, whereas MIPC levels increase and M(IP)2C levels remain con-
stant (Klose et al., 2012). The net result is the same as we observe 
upon deletion of SCH9, that is, a relative decrease in IPC levels com-
bined with a relative increase in MIPC and M(IP)2C levels. Thus, the 
complex sphingolipid profile of a sch9Δ strain reflects that of a WT 
Because this effect of rapamycin addition is abrogated in sch9Δ 
cells, this suggests that Sch9 functions to repress ceramidase levels 
downstream of TORC1. Concerning the levels of the ceramide syn-
thases, we also observed an increase in the levels of Lag1 and Lac1 
in the sch9Δ strain, although the effects on Lac1 were not statistically 
significant. Of importance, this increase in Lag1/Lac1 levels is not 
seen when treating WT or sch9Δ cells with rapamycin. One possible 
explanation is that Sch9 might specifically regulate ceramide syn-
thase levels, independent of TORC1. Note, however, that the ra-
pamycin treatment represents a short-term response to TORC1 in-
activation, whereas conditions for the sch9Δ strain represent a 
steady state of this strain during growth. Therefore, an alternative 
explanation is that during steady-state growth under nutrient-rich 
conditions, the increased abundance of ceramidase enzymes in the 
sch9Δ strain may trigger additional (TORC1-independent) homeo-
static mechanisms, which increase Lag1/Lac1 levels to try to com-
pensate the imbalanced sphingolipid rheostat. Because elevated 
levels of phosphorylated LCBs act as inhibitory to growth (Kim et al., 
2000), this compensatory response could function to reduce LCB(P) 
levels to some extent to avoid complete growth inhibition.
Sch9 controls de novo ceramide synthesis via transcriptional 
regulation mechanisms
To investigate whether the changes in protein levels under our ex-
perimental conditions reflect a transcriptional response, we con-
structed lacZ reporter fusions with the promoters of LAG1, LAC1, 
YDC1, and YPC1 in the multicopy plasmid Yep357. First, Figure 5A 
shows that deletion of SCH9 indeed results in a significant induction 
in reporter activity for both the ceramide synthase promoters, LAG1 
and LAC1, as for the ceramidase promoters YDC1 and YPC1. This 
induction in the sch9Δ strain was higher for the ceramidase promot-
ers compared with the induction of the promoters of the ceramide 
synthase genes, and as such correlates with our observation that 
the increase in protein levels for Ydc1-Myc and Ypc1-Myc is larger 
than the increases in Lag1-Myc and Lac1-Myc levels in the sch9Δ 
strain (Table 1). Second, treatment of the WT strain with rapamycin 
resulted in significant transcriptional induction in ceramidase pro-
moter activity for both the YDC1 and YPC1 reporters, whereas such 
an induction was absent for both the LAG1 and LAC1 reporters 
(Figure 5B). The fact that derepression of the ceramidase enzymes is 
higher in sch9Δ cells than in WT cells treated with rapamycin might 
be due to the fact that our rapamycin treatment does not result in a 
complete inactivation of Sch9, especially in the BY4741 strain, which 
is more resistant to rapamycin treatment than most other back-
grounds. Finally, the rapamycin-induced effect on the YDC1 and 
YPC1 reporters was abrogated in the sch9Δ strain (Figure 5C). As 
such, the effects on the Myc-tagged protein levels shown in Figure 
4 are recapitulated on a transcriptional level by our lacZ results 
shown in Figure 5. Thus, Sch9 seems, indeed, to be the downstream 
effector of the TORC1 kinase in the transcriptional control of cerami-
dase expression. However, one may argue that the absence of ra-
pamycin-induced expression of the YDC1 and YPC1 reporters in the 
sch9Δ strain may be due to an already complete derepression of 
promoter activity. Furthermore, induction of ceramidase promoter 
activity by rapamycin treatment in the WT strain might be due to 
Sch9-dependent and -independent effects, for instance through the 
Tap42 signaling branch of TORC1 (Smets et al., 2010). To further 
demonstrate that Sch9 is the principal mediator of the observed 
rapamycin effects, we used SCH9 constructs in which specifically the 
five TORC1 phosphorylation sites were mutated (Urban et al., 2007). 
Mutation of these sites to alanine (SCH95A) results in the expression 
of an inactive Sch9 protein that cannot be phosphorylated by 
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FIGURE 2: Deletion of SCH9 confers resistance to myriocin and increases sensitivity to phytosphingosine and 
aureobasidin A. (A) Serial dilutions of exponentially growing wild-type and sch9Δ cells of two different genetic 
backgrounds (BY4741 and W303-1A) and with different markers were spotted on YPD and on YPD containing 0.5 μg/ml 
myriocin. (B) Serial dilutions of sch9Δ cells (BY4741 background, JW 01 306), transformed with YEpLac195 (ev) or 
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complex sphingolipids may also contribute to myriocin resistance 
(Supplemental Figure S1A). Specifically interesting to us was the 
observation that additional deletion of ISC1 resulted in an increase 
in myriocin resistance of the sch9Δ strain (Figure 1SB). This result 
indicates a functional link between Sch9 and Isc1, the inositol phos-
phosphingolipid phospholipase C, which hydrolyses IPC, MIPC, 
and M(IP)2C back into (phyto)ceramides (Sawai et al., 2000). We 
first examined whether Sch9 might influence Isc1 protein levels, 
similar to the situation seen for the enzymes involved in de novo 
ceramide synthesis. To this end, we constructed WT and sch9Δ 
strains expressing a chromosomally encoded, Myc-tagged version 
of Isc1. Determination of the levels of Isc1-Myc in exponentially 
growing cells demonstrated that deletion of SCH9 or treatment of 
yeast strain in stationary phase, consistent with the model that Sch9 
activity signals the presence of nutrients (Urban et al., 2007). The 
reduction of IPC could be explained by the reduced content of 
(phyto)ceramides, which serve as precursors. However, the incre-
ment in the levels of mannosylated sphingolipids suggests an ad-
ditional regulatory role for Sch9 in the biosynthesis or turnover of 
mannosylated sphingolipids.
Sch9 affects the mitochondrial translocation of Isc1
To further decipher the connection between Sch9 and complex 
sphingolipid synthesis, we performed a genetic analysis on myrio-
cin resistance of an sch9Δ strain lacking additional genes involved 
in the synthesis of complex sphingolipids. Results indicated that 
FIGURE 3: The levels of LCBs, LCB-phosphates, and ceramides are altered in sch9Δ cells. Sphingolipids were purified 
from wild-type (W303-1A; closed bars) and sch9Δ (JW 01 418; open bars) cells growing exponentially in YPD medium, 
analyzed by LC-MS, and normalized by organic phosphates: (A) Phytosphingosine and dihydrosphingosine bases and 
their phosphates, (B) dihydroceramide species (DHCer) with acyl chains of different length, (C) phytoceramide species 
(PhytoCer) with acyl chains of different length, and (D) αOH-PhytoCer with acyl chains of different length. The results 
are mean values ± SD of lipid measurements from three independent cultures measured in duplicate.
YEpLac195/SCH9 (SCH9) were spotted on YPD and on YPD containing 0.5 μg/ml myriocin. (C) Exponentially growing 
wild-type (W303-1A background) and sch9Δ (JW 01 418) cells were treated for 2 h with 0.5 μg/ml myriocin and stained 
with propidium iodide to visualize dead cells. Results are mean values ± SD of three independent cultures. At least 
200 cells were counted for each experiment. (D) Northern blot analysis of the myriocin (0.5 μg/ml)-induced 
transcriptional response in wild-type (W303-1A) and sch9Δ (JW 00 035) cells of two typical ribosomal protein genes, 
RPS10a and RPL30. 18S was used as a loading control. Samples were taken at the indicated time points. (E) Growth of 
wild-type (W303-1A; closed symbols) and sch9Δ (JW 00 035; open symbols) cells was monitored during growth on YPD 
without or with supplementation of the indicated amounts of PHS. To dissolve PHS, 0.0015% of the detergent Nonidet 
P-40 was added together with PHS. (F) Sensitivity of wild-type (W303-1A) and sch9Δ (JW 00 035) cells to aureobasidin A 
(1 mg/ml), as assessed via a growth-inhibitory halo assay on YPD agar plates.
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In agreement with previous work, we ob-
served Isc1-GFP localization at the ER in 
WT and sch9Δ cells during exponential 
growth (Vaena de Avalos et al., 2004), with 
almost no sign of mitochondrial colocaliza-
tion (Supplemental Figure S3). In the post-
diauxic growth phase, Isc1-GFP mainly co-
localized with mitochondria in WT cells, 
whereas in sch9Δ cells, Isc1-GFP remained 
mostly localized at the ER (Supplemental 
Figure S3), indicating involvement of Sch9 
in mitochondrial translocation of Isc1 on 
galactose-containing medium. We were cu-
rious as to whether Isc1 also translocates to 
the mitochondria in the postdiauxic phase 
of cells grown on glucose-containing me-
dium and whether deletion of SCH9 would 
have a similar effect under these conditions. 
Furthermore, because we determined our 
sphingolipid profiles for cells growing on 
glucose as the carbon source, studying the 
intracellular localization of Isc1in cells grown 
on glucose could be directly related to our 
observed sphingolipid profiles. To this end, 
we subcloned the ISC1-GFP construct be-
hind its own promoter. In addition, we 
made two parallel analyses of Isc1-GFP lo-
calization: in a first series of experiments, 
we scored colocalization of Isc1 with an 
ER-specific mCherry marker (Figure 8A), 
whereas colocalization with mitochondria 
was analyzed in a second series of experi-
ments using a mCherry marker targeted to 
the mitochondria (Figure 8B). For both the 
WT and sch9Δ strains, we saw that in cells 
growing exponentially on glucose, Isc1 lo-
calized almost exclusively in the perinuclear 
and cortical ER (Figure 8A), without any sig-
nificant colocalization with mitochondria 
(Figure 8B). When scoring colocalization of 
Isc1 with the ER in cells in the postdiauxic 
phase, we noticed a higher retention of Isc1 
in the ER in sch9Δ cells than in WT cells 
(Figure 8A). Consistent with this observa-
tion, postdiauxic-phase WT cells showed 
more colocalization of Isc1 with the mito-
chondrial marker than sch9Δ cells (Figure 
8B). Therefore we conclude that deletion of 
SCH9 impairs mitochondrial translocation 
of Isc1 in postdiauxic-phase cells in both glucose- and galactose-
grown cells.
Implications of the functional interaction between Sch9 
and Isc1 for yeast longevity
Consistent with Sch9 acting as a regulator of Isc1, several studies 
documented that Isc1 plays a role in well-known Sch9-dependent 
phenotypes, including diauxic shift reprogramming and respiration, 
oxidative stress resistance, and the determination of longevity 
(Almeida et al., 2008; Kitagaki et al., 2009; Barbosa et al., 2011). 
Intriguingly, although loss of Sch9 is known to trigger increased re-
sistance to oxidants and increased chronological life span (Fabrizio 
et al., 2001; Wei et al., 2009), loss of Isc1 is associated with a higher 
cells with rapamycin did not alter Isc1-Myc levels (Supplemental 
Figure S2).
Previous studies demonstrated that Isc1 gains activity during 
the diauxic shift, when it translocates from the ER to the outer 
membrane of mitochondria, where the enzyme is required to pro-
duce a subset of phytoceramides, especially αOH-PhytoCer-C26 
(Vaena de Avalos et al., 2004, 2005; Kitagaki et al., 2007). Because 
Sch9 plays a pivotal role in the diauxic shift transition (Pedruzzi 
et al., 2003; Roosen et al., 2005), we set out to monitor and com-
pare the intracellular localization of Isc1 in WT and sch9Δ cells dur-
ing different growth phases. Initially, we used a galactose-induced 
Isc1–green fluorescent protein (GFP) expression construct in com-
bination with a red fluorescent mitochondrial marker protein. 
FIGURE 4: Sch9 affects protein levels of enzymes involved in de novo ceramide synthesis and 
breakdown. Genes encoding the enzymes of ceramide synthase (LAG1 and LAC1) or 
ceramidase (YDC1 or YPC1) were genomically tagged with a 9Myc tag in both WT BY4741 and 
sch9Δ (JW 03 038) strains. Overnight precultures were inoculated at initial OD600 of 0.3 and 
grown to OD600 of 2.0, after which a sample was withdrawn for protein extraction (noted as –). 
The remainder of the culture was treated with 200 nM rapamycin and grown for an additional 1 
h, after which a second sample for protein extraction was taken (noted as +). After TCA protein 
extraction, equal protein amounts were run on a SDS–PAGE. Tagged enzymes were detected 
using an anti-Myc antibody; the yeast Adh2 serves as an internal control. Representative results 
for Western blots are shown for (A) Lag1-9Myc, (B) Lac1-9Myc, (C) Ydc1-9Myc, and (D) Ypc1-
9Myc. Signals for Myc detection were quantified and normalized for Adh2 levels. Average 
results of two or three independent cultures are shown in E, with SD shown as error bars. 
Statistical significance was determined by unpaired t tests for effects between the WT and 
sch9Δ strains, and paired t tests for effects of rapamycin. Because several experimental 
manipulations in Western blot experiments, such as variations in blotting efficiency, antibody 
activity, and so on, increase variability not related to the intrinsic properties of the protein 
samples, we set the threshold for statistical significance at p < 0.1 instead of the usual threshold 
of p < 0.05. Results of the t tests are shown as ^p < 0.1, *p < 0.05, and ***p < 0.001.
Volume 25 January 1, 2014 Sch9 and yeast sphingolipid metabolism | 203 
species (ROS) under the same conditions, as an increase in oxidative 
stress plays a major role in determining viability in stationary phase. 
As compared with WT cells, the level of ROS was already elevated in 
exponential isc1Δ cells, and this difference became more pro-
nounced when the cells enter the stationary phase (Figure 9, B and 
C). In sch9Δ cells, the level of ROS also increased during growth, but 
here the amount of ROS was always significantly lower than in WT 
cells. Of interest, the additional deletion of SCH9 in the isc1Δ mutant 
restored the ROS production to levels comparable to those of WT 
cells (Figure 9, B and C). In line with these reductions in ROS levels, 
survival of the sch9Δ isc1Δ double mutant increased compared with 
the isc1Δ strain (Figure 9A). Finally, the decreased chronological life 
span of cells lacking Isc1 was shown to be due to increased apop-
totic cell death (Almeida et al., 2008). We confirmed the involve-
ment of apoptosis in mediating the accelerated cell death of isc1Δ 
cells by staining yeast cells with the cell death markers of apoptosis 
and necrosis (annexin/PI costaining; Supplemental Figure S4). We 
also showed that deletion of SCH9 decreases apoptotic cell death, 
independent of the presence or absence of ISC1, correlating with 
the decreased oxidative stress observed in these strains. Linking 
these viability data with our observation that Sch9 is required for 
proper mitochondrial translocation of Isc1 in postdiauxic-phase cells 
is a delicate matter. Because Isc1-mediated sphingolipid metabo-
lism in mitochondria is required for proper mitochondrial function 
and viability in stationary phase (Almeida et al., 2008; Kitagaki et al., 
2009), this would indicate a prosurvival function of Sch9 in stimulat-
ing Isc1 activity, which contradicts the increased life span of cells 
deleted for SCH9 (Figure 9A). On the other hand, decreased mito-
chondrial translocation of Isc1 in the sch9Δ mutant implies a reduc-
tion of mitochondrial ceramide species produced by Isc1 in the 
postdiauxic phase of sch9Δ cells (Vaena de Avalos et al., 2005; 
Kitagaki et al., 2007). Several studies showed that ceramides can 
interact directly with mitochondria, thereby increasing mitochondrial 
membrane permeability (Birbes et al., 2001; Siskind et al., 2002, 
2005; Chipuk et al., 2012; Rego et al., 2012) and disrupting electron 
transport, resulting in elevated ROS levels (Garcia-Ruiz et al., 1997; 
Gudz et al., 1997; Di Paola et al., 2000). As such, impaired Isc1 trans-
location might be responsible for part of the increased longevity 
observed in a sch9Δ strain, although this antisurvival function of Isc1 
does not fit with the loss of viability upon deleting ISC1 in the WT or 
sch9Δ strain (Figure 9A). Clearly, more work is needed to further 
characterize the molecular connections between Sch9 and Isc1 func-
tions. For instance, although it was proven that Isc1 activity increases 
upon translocation to the mitochondria (Vaena de Avalos et al., 
2004, 2005), it may also posses (basal) enzymatic activity at the ER. 
Future studies may test the effect of Sch9 specifically on the enzy-
matic activity of Isc1 at these different cellular locations. Further-
more, due to the plethora of ceramide species, it is conceivable that 
specific ceramide species, possibly generated at different intracel-
lular locations, mediate different cellular responses, thereby regulat-
ing either survival or death, depending on the cellular context 
(Hannun and Obeid, 2011; Matmati et al., 2013). Of interest, the 
complex sphingolipids, whose profile is also altered by deletion of 
SCH9, were recently demonstrated to influence yeast viability, inde-
pendent of their ceramide precursors (Kajiwara et al., 2012). As such, 
these species should not be overlooked when building a model for 
the cell death/survival mechanisms operating in yeast cells.
DISCUSSION
Sch9 is a regulator of sphingolipid metabolism
Regulation of the sphingolipid rheostat is essential for yeast cells to 
ensure proper growth and survival properties (Dickson, 2010). 
oxidative stress sensitivity and reduced chronological life span 
(Almeida et al., 2008). To further elaborate on the functional interac-
tion between Sch9 and Isc1, we determined the chronological life 
span of mutants lacking SCH9 and/or ISC1 (Figure 9A). In agree-
ment with previous published results, we observed an increase in life 
span in the sch9Δ mutant as compared with the WT strain (Fabrizio 
et al., 2001; Wei et al., 2009), whereas the isc1Δ mutant displayed 
reduced viability (Kitagaki et al., 2009; Barbosa et al., 2011). In paral-
lel with viability, we assessed the levels of cellular reactive oxygen 
FIGURE 5: Transcriptional control by Sch9 of genes encoding 
enzymes involved in de novo ceramide synthesis and breakdown. 
Promoters of genes LAG1, LAC1, YDC1, and YPC1 were cloned into 
the lacZ reporter plasmid YEp357 as described in Materials and 
Methods and transformed into the WT BY4741 and sch9Δ (JW 03 038) 
strains. Precultures were grown overnight in SD-URA, inoculated into 
YPD medium, and grown for 6–7 h, after which part of the culture was 
treated with 200 nM rapamycin. After 1 h, samples of treated and 
untreated cells were pelleted at 4°C and stored at −80°C. Protein 
extracts were prepared, and specific activities were determined. 
Results are expressed as mean of four independent transformants, 
with SD noted as error bars. Results displayed in A indicate a 
significant increase in lacZ activities in the sch9Δ strain compared with 
the WT strain (**p < 0.01, ***p < 0.001, unpaired t test). Rapamycin-
dependent effects in WT and sch9Δ cells are separately displayed in B 
and C, respectively, for extra clarity. Only in the WT strain was there a 
significant increase in YDC1- and YPC1-lacZ activities observed after 
addition of rapamycin to the cells (*p < 0.05, **p < 0.01, paired t test).
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obtained by short-term rapamycin treatment, steady-state levels of 
complex sphingolipids may thus be regulated by TORC1 through 
both the Sit4-Npr1 effector branch and the Sch9 effector branch, 
the latter being supported by this work.
Concerning the LCB(P)/ceramide rheostat, we demonstrate a 
novel mechanism in which Sch9 controls the presence of the Ydc1 
and Ypc1 ceramidase enzymes. Using promoter-lacZ reporter 
constructs, we demonstrate that Sch9 performs this function by 
acting at the transcriptional level, with deletion of SCH9 resulting in 
a significant derepression of YDC1 and YPC1 expression. Treating 
WT cells with rapamycin, which inhibits the nutrient-dependent ki-
nase TORC1, also results in derepression of YDC1 and YPC1, and we 
show that this effect is mediated by Sch9, which is known to act as a 
downstream effector of TORC1 (Urban et al., 2007). Therefore we 
conclude that signaling through the TORC1–Sch9 pathway during 
nutrient-rich conditions serves to repress transcription of the YDC1 
Therefore it is not surprising that this sphingolipid balance changes 
when nutrient conditions alter. In this study, we observed that, dur-
ing growth, the sch9Δ strain displays sphingolipid profiles described 
for cells in stationary phase. Indeed, compared with the WT strain, 
sch9Δ cells accumulate LCB(P)s and have decreased (phyto)cer-
amide levels and an altered profile of complex sphingolipids, which 
is similar to cells entering into stationary phase (Klose et al., 2012; 
Lester et al., 2013). The specific increase of mannosylated sphingo-
lipid species compared with IPC levels indicates that Sch9 has ad-
ditional inputs into complex sphingolipid synthesis, apart from its 
role in maintaining the LCB(P)/ceramide balance. Interestingly, 
TORC1 inhibition has been reported to stimulate complex sphingo-
lipid synthesis through Npr1-dependent phosphorylation of the 
Orm1/2 proteins (Shimobayashi et al., 2013). The molecular mecha-
nism behind this phenotype is unknown, although it was shown to 
be independent of SPT activity. Given that these results were 
FIGURE 6: The rapamycin-induced effects on YDC1 and YPC1 lacZ activity are mediated by Sch9. LacZ activities of the 
YDC1 (left) and YPC1 (right) promoters was assessed in the sch9Δ strain (JW 03 038) coexpressing the empty vector 
(EV, pRS415), the wild-type SCH9 gene, or one of the SCH9 mutant genes in which its TORC1 phosphorylation sites are 
mutated to either alanine (SCH95A) or glutamic/aspartic acid residues (SCH92D3E). The WT strain (BY4741) coexpressing 
the EV was taken as an additional control. Precultures were grown overnight in SD-URA-LEU, inoculated into YPD 
medium, and grown for 6–7 h, after which part of the culture was treated with 200 nM rapamycin. After 1 h, samples of 
treated and untreated cells were pelleted at 4°C and stored at −80°C. Protein extracts were prepared, and specific 
activities were determined. Results are expressed as mean of four independent transformants, with SD noted as error 
bars. Top: all results in one graph. Bottom: for clarity, selective omission of results of conditions that mimic the condition 
of the sch9Δ strain with the EV. Results for both promoters are equivalent, in that the SCH95A construct mimics the 
absence of SCH9 in its high basal lacZ activity and no induction by rapamycin. The SCH92D3E construct, on the other 
hand, gives basal lacZ activities compared with the SCH9 control strain, although induction by rapamycin is lost due to 
the inability of the Sch92D3E protein to be inhibited by loss of TORC1 activity. Statistical significance of rapamycin 
addition for each construct was assessed by a paired t test (**p < 0.01, ***p < 0.001).
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eukaryotes, the balance in intermediary sphingolipid signaling me-
tabolites, the so-called sphingolipid rheostat, has an important func-
tion in cell survival, disease and senescence (Olivera et al., 1999; 
Levade et al., 2002; Hait et al., 2006; Saddoughi et al., 2008; Breslow 
and Weissman, 2010; Dickson, 2010; Bikman and Summers, 2011; 
Van Brocklyn and Williams, 2012). Therefore it is not surprising that 
the altered sphingolipid profile we describe for sch9Δ cells may have 
important contributions to the increased life span of this strain.
The increased survival of the sch9Δ strain is reported to be partly 
due to increased mitochondrial function and respiration during 
growth (Lavoie and Whiteway, 2008; Pan and Shadel, 2009; Pan 
et al., 2011). Of interest, the elevated PHS-P levels of sch9Δ cells we 
demonstrated in this study might be crucial for this process, as cel-
lular PHS-P have been implicated in the control of the HAP complex 
transcription factor (Cowart et al., 2010), which regulates mitochon-
drial respiration. As such, our results would provide the missing 
mechanistic link between Sch9 and the Hap4 transcription factor, 
which was shown to be essential for the increased cellular respira-
tion in sch9Δ cells (Lavoie and Whiteway, 2008).
The decreased ceramide levels may also contribute to the in-
creased life span of the sch9Δ strain. Indeed, evidence indicates that 
ceramides can induce a mitochondrial cell death pathway in yeast, 
which seems to involve increasing mitochondrial membrane perme-
ability (Carmona-Gutierrez et al., 2011; Rego et al., 2012). In addi-
tion, ceramides exert proapoptotic effects via ceramide-activated 
protein phosphatases, such as Sit4 in yeast (Nickels and Broach, 
1996; McCourt et al., 2009; Barbosa et al., 2011). In addition to the 
aforementioned effect of Sch9 on the de novo synthesis of cer-
amides, we demonstrate that Sch9 is required for the proper mito-
chondrial localization of Isc1 in postdiauxic cells, which, to our 
knowledge, is the first report of a protein required for Isc1 transloca-
tion (Vaena de Avalos et al., 2004, 2005; Kitagaki et al., 2007). Given 
that this translocation of Isc1 is blocked in sch9Δ cells, this may 
abrogate the production of a specific mitochondrial ceramide pool, 
and YPC1 ceramidase-encoding genes. We also observed TORC1-
independent effects on the expression of the ceramide synthase 
genes LAG1 and LAC1 in the sch9Δ strain. However, we cannot 
discriminate between whether this represents a true Sch9-depen-
dent, TORC1-independent, signaling event or is due to additional, 
Sch9-independent homeostatic mechanisms that counteract the sig-
nificant increased ceramidase presence in the sch9Δ strain. Identifi-
cation of the transcription factors involved in these processes, which 
is currently being pursued, will help to shed light on this issue.
It is intriguing that, besides TORC1, multiple in vitro and in vivo 
studies show that Sch9 activity is also regulated independently by 
the LCB (PHS)-dependent Pkh1/2 kinases (Roelants et al., 2004; Liu 
et al., 2005; Urban et al., 2007; Voordeckers et al., 2011; Huang et al., 
2012). According to this model, if PHS drops (e.g., by myriocin treat-
ment), Sch9 activity will also drop due to reduced phosphorylation by 
Pkh1/2. This would lead to increased ceramidase action, helping to 
restore internal LCB pools. Therefore Sch9 comprises a major gate-
keeper of sphingolipid homeostasis, optimizing ceramidase activity 
by integrating information on internal LCB (PHS) levels through 
Pkh1/2, as well as information on nutritional status via TORC1, 
thereby adjusting sphingolipid metabolite levels to cellular needs. 
Given that Orm1/2-mediated regulation of sphingolipid metabolism 
was shown to be mainly regulated via (rapid) Orm1/2 phosphoryla-
tion, the Sch9-mediated transcriptional response may comprise a 
complementary mechanism, operating somewhat more slowly, as it 
is dependent on transcription, although probably essential to gener-
ate major long-term changes in the sphingolipid rheostat.
Altered sphingolipid levels and longevity in sch9Δ cells
A well-established phenotype of the sch9Δ strain is its increased 
survival during stationary phase (Fabrizio et al., 2001; Wei et al., 
2009), and much research has been performed to elucidate the 
mechanisms behind this phenotype. Sphingolipids are also crucial 
regulators of cell viability, and it has been shown that in higher 
Proteina Fold increase Significance lacZ constructb Fold increase Significance
Fold increase in sch9Δ vs. WT strain
Lag1-9Myc 1.8 ^ LAG1pr 4.9 ***
Lac1-9Myc 1.4 ns LAC1pr 5.4 ***
Ydc1-9Myc 2.9 * YDC1pr 13.4 ***
Ypc1-9Myc 2.4 * YPC1pr 18.7 **
Fold increase after addition of rapamycin to WT cells
Lag1-9Myc 1.1 ns LAG1pr 1.1 ns
Lac1-9Myc 1.0 ns LAC1pr 0.8 ns
Ydc1-9Myc 2.3 ^ YDC1pr 2.0 *
Ypc1-9Myc 2.2 *** YPC1pr 2.0 **
Fold increase after addition of rapamycin to sch9Δ cells
Lag1-9Myc 1.2 ns LAG1pr 1.3 ns
Lac1-9Myc 0.8 ns LAC1pr 1.1 ns
Ydc1-9Myc 1.0 ns YDC1pr 1.1 ns
Ypc1-9Myc 1.1 ns YPC1pr 1.0 ns
Statistical significance was determined using an unpaired t test for the effects of sch9Δ vs. WT strain, and paired t tests for the effects of rapamycin addition. Statisti-
cal significance: ^p < 0.1 (only used for protein levels), *p < 0.05, **p < 0.01, and ***p < 0.001.
aAnalysis of results shown in Figure 4.
bAnalysis of results shown in Figure 5.
TABLE 1: Effects of SCH9 deletion and rapamycin addition on protein levels and lacZ promoter constructs.
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the mechanisms described here are conserved in higher eukaryotes. 
Furthermore, the altered sphingolipid profile exhibited by the sch9Δ 
strain provides additional molecular links that help explain the ex-
tended life span of this strain. As such, it appears that changing the 
sphingolipid balance in yeast by tipping it in favor of the (LCBs and) 
LCBPs, concomitant with decreased ceramide levels, results in lower 
apoptosis and increased survival, which in many ways is similar 
to what is seen for mammalian cells (Olivera et al., 1999; Levade 
et al., 2002; Hait et al., 2006; Saddoughi et al., 2008; Bikman and 
Summers, 2011; Van Brocklyn and Williams, 2012). Given this con-
served nature of the role of sphingolipid signaling in eukaryotic 
cells, yeast may continue to serve as an important model system for 
higher eukaryotes.
MATERIALS AND METHODS
Materials, yeast strains, plasmids, and growth media
S. cerevisiae strains and plasmids used in this study are listed in 
Supplemental Tables S1 and S2, respectively. Deletion strains were 
made using PCR-derived deletion cassettes (Brachmann et al., 
which could contribute to apoptotic cell death, as demonstrated in 
both yeast and mammals (Birbes et al., 2001; Chipuk et al., 2012; 
Rego et al., 2012). Still, we and others have shown that loss of ISC1 
impairs survival during stationary phase (Almeida et al., 2008; 
Kitagaki et al., 2009; Barbosa et al., 2011), indicating that Isc1-me-
diated ceramide production can elicit prosurvival and antisurvival 
programs, depending on specific cellular conditions. Finally, since 
Sch9 activity is proposed to decline upon nutrient depletion, this 
indicates that Sch9 affects the translocation of Isc1 indirectly. Given 
that sch9Δ cells were shown to have altered mitochondrial proper-
ties, such as reduced superoxide production, in stationary phase 
(Pan and Shadel, 2009; Pan et al., 2011), our experimental observa-
tions support a model in which mitochondrial ROS production may 
provide the cellular signal for Isc1 translocation.
In conclusion, we show that the TORC1–Sch9 signaling branch 
controls sphingolipid homeostasis by controlling the expression of 
the ceramidase enzymes. Given that transcriptional regulation 
mechanisms of sphingolipid metabolism are still largely elusive 
(Breslow and Weissman, 2010), it will be of interest to see whether 
FIGURE 7: The complex sphingolipid profile is changed in sch9Δ cells. Negative-ion ESI/MS spectra of complex 
sphingolipids from wild-type (W303-1A; open bars) and sch9Δ (JW 01 418; closed bars) mutants. Sphingolipids were 
purified from wild-type and sch9Δ cells growing exponentially in YPD medium. The three different classes of complex 
sphingolipids—IPCs, MIPCs, and M(IP)2Cs—are indicated. (A) Representative spectrum from two independent 
measurements. (B) Quantifications of relative levels.
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FIGURE 8: Fluorescence microscopic analysis of the intracellular localization of Isc1. Intracellular localization of Isc1-GFP 
expressed from its own promoter (plasmid FBp708) in wild-type (BY4741) and sch9Δ (JW 03 038) cells was examined 
by assessing colocalization with a mCherry marker targeted to the ER or the mitochondria. Cells precultured on 
SD-URA-LEU were inoculated in fresh YPD medium (2% glucose) at an initial OD600 of 0.5. Pictures were taken after 
6–8 h (exponential) and after 28 h (postdiauxic). Representative pictures are shown for each condition, showing (from 
left to right) bright field, green channel (GFP), red channel (mCherry), and the corresponding merged picture. 
(A) Colocalization with the ER. During exponential growth, nearly all cells displayed colocalization of Isc1-GFP with the 
ER-mCherry marker (plasmid FBp709). In postdiauxic-phase cells, two distinct populations are observed, showing either 
an overlap or no overlap with the ER. (B) Colocalization with mitochondria. During exponential growth, virtually no cells 
displayed colocalization of Isc1-GFP with the mitochondria-mCherry marker (plasmid FBp459). In postdiauxic phase 
cells, two distinct populations are observed, showing either an overlap or no overlap with the mitochondrial marker. For 
each condition, overlap was assessed in 100–150 cells of three independent transformants. Average results of overlap 
are noted with SDs, and unpaired t tests were performed to designate statistical difference of each type of 
colocalization between the WT strain and the sch9Δ strain at the postdiauxic phase (*p < 0.05, ***p < 0.001).
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to myriocin (Sigma-Aldrich, St. Louis, MO) was assayed by spotting 
5-μl samples of 10-fold serial dilution of these yeast cultures on YPD 
plates containing 0.5 μg/ml myriocin. Growth was assessed after 
48 h of incubation at 30°C. To determine sensitivity of the yeast 
cultures to aureobasidin A, 0.5 ml of these cultures was used to 
inoculate an YPD agar plate on which Whatman paper disks were 
placed containing 5 μl of 1 mg/ml aureobasidin A (Takara Bio, Shiga, 
Japan) in water. After 3 d of incubation at 30°C the size of the halo 
was measured. To assess sensitivity of yeast cultures to phytosphin-
gosine (Sigma-Aldrich), cells were grown to stationary phase (>5 d) 
in YPD and subsequently diluted to an OD600 of 0.05 in YPD con-
taining 5 or 15 μM phytosphingosine and 0.0015% Nonidet P-40. 
The OD600 of the different cultures was measured at regular time 
1998). Yeast strains were grown at 30°C in YP (1% yeast extract, 2% 
bactopeptone [OXOID, Aalst, Belgium]) or in synthetic growth 
medium (SG; 0.5% ammonium sulfate, 0.17% yeast nitrogen base 
without amino acids and without ammonium sulfate, and the 
appropriate synthetic drop-out amino acid/nucleotide mixture 
[ForMedium, Norfolk, UK]) supplemented with either 2% glucose (D) 
or 2% galactose (GAL) as indicated. Sporulation and tetrad analysis 
was carried out as described previously (Swinnen et al., 2005).
Drug sensitivity assays
For analysis of sensitivity to myriocin and aureobasidin A, overnight 
yeast cultures in YPD were diluted to an OD600 of 0.5 in YPD and 
further incubated at 30°C for 4–6 h. Sensitivity of the yeast cultures 
FIGURE 9: Control of viability and oxidative stress by SCH9 and ISC1 during chronological aging. (A) Chronological life 
span experiment. The viability of the wild-type (BY4741), sch9Δ (JW 01 306), isc1Δ, and sch9Δisc1Δ strains was 
measured by determining the colony-forming units (CFUs), expressed as percentage of CFUs observed at time 0 h. 
(B, C) The indicated strains were stained with dihydroethidium (DHE) for measurement of ROS accumulation after 16 h 
(exponential phase) and 96 h (stationary phase) of growth. (B) Fluorescence microscopic visualization of DHE-stained 
cells. (C) ROS levels quantified by fluorescence measurements (excitation, 535 nm; emission, 595 nm) and normalized for 
cell number. ROS levels of the WT strain at 16 h was set as 100%. Results in A and C are mean values of three 
independent cultures; error bars represent SD. In C, unpaired t tests were performed to designate statistical difference 
with ROS levels in the WT strain at the same time point (*p < 0.05, ***p < 0.001).
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(16.1 g of Na2HPO4⋅7H2O, 5.5 g of NaH2PO4⋅H2O, 0.75 g of KCl, 
246 mg of MgSO4⋅7H2O per liter) containing proteinase inhibitor 
cocktail tablets (Complete Mini, EDTA free; Roche Diagnostics) and 
broken using glass beads. The clarified extract was diluted in break-
ing buffer to a total volume of 100 μl and incubated at 30°C for 
5 min before the reaction was initiated by adding 20 μl of 4 mg/ml 
o-nitrophenylgalactoside (Sigma-Aldrich). At a precise time, the re-
action was terminated by addition of 50 μl of 1 M Na2CO3. OD405nm 
was measured, and protein concentration was determined accord-
ing to the Bradford method. We calculated specific activity from 
1.7OD405nm/(0.0045 × protein concentration × extract volume × 
time), expressed as nmol/min mg protein. Data are the mean of 
three independent transformants. Error bars represent SD.
Fluorescence microscopy
To study intracellular localization of Isc1, we received a construct 
expressing Isc1-GFP under the galactose-inducible promoter of the 
pYES2 vector (FBp431; Vaena de Avalos et al., 2004). To study Isc1-
GFP localization under conditions using glucose as a carbon source, 
we cloned ISC1-GFP behind its native promoter into plasmid 
pRS426 (2 μ, URA3). For this, we used plasmid FBp431 as a tem-
plate for PCR of the ISC1-GFP fusion construct using primers ISC1-
fus5 and ISC1-fus4. Yeast genomic DNA was used for PCR of the 
ISC1 promoter using primers ISC1-fus1 and ISC1-RVC. Both PCR 
products contain overlapping ends with the pRS426 vector and 
each other, and a cotransformation of both PCR products with 
EcoRI-linearized pRS426 into yeast resulted in in vivo recombination 
to yield plasmid FBp708 (pISC1pr-ISC1-GFPuv construct in pRS426). 
Correct cloning was confirmed by sequencing. Intracellular localiza-
tion of Isc1-GFP was scored by assessing colocalization with mCherry 
markers for mitochondria (plasmid FBp459; mCherry targeted to the 
mitochondria by the Cox4 presequence) and the ER (plasmid 
FBp709). The latter plasmid was created in analogy with the strategy 
used by Okamoto et al. (2006). In short, an ER-targeted version of 
mCherry was made by fusing the Kar2p signal-peptide sequence 
(first 135 nucleotides) to the coding region of mCherry containing a 
C-terminal HDEL retention sequence. This was achieved by cotrans-
formation of PCR products using primers KAR2-F1 and KAR2-F2 
(genomic DNA template) and primers mCherry-F1 and mCherry-F2 
(FBp459 template), with a BamHI-linearized pYX242 plasmid. After 
recombination in yeast, plasmid FBp709 was formed, expressing 
the KAR2(1→135)-mCherry-HDEL fusion from the TPI promoter. Plas-
mids used are listed in Supplemental Table S2 and primers in Sup-
plemental Table S3. Colocalization of Isc1-GFP (plasmid FBp431 or 
FBp708) with mCherry (plasmid FBp459 or FBp709) was carried out 
using a Leica DM 4000B fluorescence microscope (Leica Microsys-
tems, Diegem, Belgium), and images were taken with a Leica DFC 
420c camera using Leica Application software. Cultures were pre-
grown overnight on SG medium lacking uracil and leucine and 
transferred to YPGAL (FBp431) or YPD (FBp708) medium at an initial 
OD600 of 0.5. Green and red fluorescence was monitored after 6–8 h 
(exponential phase) and after 28 h (postdiauxic phase).
Chronological life span analysis and determination of ROS
For the analysis of chronological life span, cultures were pregrown in 
SG complete growth medium and diluted in flasks to an OD600 of 
0.1 in SG complete medium containing 2% glucose for 28 h, which 
was set as time zero for longevity assessment. At the indicated time 
points, cells were plated out on YPD agar plates, and colony-form-
ing units were counted after 2 d of incubation at 30°C. For determi-
nation of ROS accumulation, cells were stained with dihydroethid-
ium, pictures were taken with the fluorescence microscope, and 
points. For PI staining, yeast cells growing exponentially in YPD me-
dium were treated for 2 h with 0.5 μg/ml myriocin. Next cells were 
collected, washed in phosphate-buffered saline, and stained with 
PI using the Annexin-V-Fluos Staining Kit (Roche Diagnostics, 
Vilvoorde, Belgium) according to the provided protocol.
Northern blot analysis
Cells were grown to an OD600 of 1.5 for a period of at least 24 h by 
repeated dilution. Samples were taken at the indicated time points, 
before and after the addition of 0.5 μg/ml myriocin. RNA extraction, 
probe preparation, and Northern blotting were performed as de-
scribed previously (Swinnen et al., 2005). Hybridized blots were ex-
posed to phosphorimager screens, and images were scanned with 
a Bas 1000 PhosphorImager (Fujix, Tokyo, Japan).
Sphingolipid analysis
Sphingolipid labeling and sphingolipidomics were performed as de-
scribed previously (Kitagaki et al., 2007; Thevissen et al., 2010). In 
short, yeast cells growing exponentially in YPD medium were snap 
frozen in a methanol–dry ice bath and stored at –80°C. Electrospray 
tandem mass spectrometry (ESI-MS/MS) analysis of endogenous 
LCBs, their phosphates, and nonhydroxylated phytoceramide and di-
hydroceramide species was performed on a Thermo Finnigan TSQ 
7000 triple quadrupole mass spectrometer (Thermo Scientific, 
Waltham, MA). Sphingolipid levels were expressed in pmol, normal-
ized for the level of phospholipids (Pi, in nmol) present in the Bligh-
Dyer lipid extract: pmol/nmol of Pi (Bligh and Dyer, 1959). For the 
analysis of complex inositolphosphoryl-containing sphingolipids, ex-
tracts were made from yeast cells grown to an OD600 of 5 in YPD 
medium using a procedure described previously (Stock et al., 2000). 
Sphingolipid analysis of the extracts was performed using ESI-MS on 
a Finnigan LCQ Deca mass spectrometer (Thermo Scientific) in the 
negative mode. Spectra were averaged over 100 scans. MS data were 
analyzed using Xcalibur software from Finnigan (Aerts et al., 2006).
Trichloroacetic acid protein extraction and Western blot
Samples for protein extraction were washed with 20% trichloro-
acetic acid (TCA) and stored at −80°C for extraction. Cells were re-
suspended in 20% TCA and broken with glass beads. Extracts were 
spun down at 4°C for 15 min at 13,000 rpm, and the pellet was 
washed twice with ice-cold acetone. Equal amounts of protein 
(Bradford quantification) were mixed with sample buffer and loaded 
onto an SDS–PAGE gel. Detection of the 9Myc-tagged proteins 
was performed with the anti-Myc antibody (BIOKE, Leiden, the 
Netherlands), and detection of internal Adh2 levels with the anti-
Adh2 antibody (Millipore, Overijse, Belgium). Signals were quanti-
fied using UVP VisionWorks LS software (VWR, Leuven, Belgium).
β-Galactosidase assay
Promoters of the LAG1, LAC1, YDC1, and YPC1 genes were ampli-
fied using primers listed in Supplemental Table S3 and cloned into 
the BamHI and SalI sites of the multicopy lacZ reporter YEp357 
(Serrano et al., 2002), yielding plasmids FBp701–704. Subcloning of 
SCH9 constructs was performed by cutting the SCH9 coding 
regions from plasmids pJU675, pJU822, and pJU841 (Urban et al., 
2007) with XhoI and HindIII and ligating them into the pRS415 
vectors, generating plasmids FBp705, FBp706, and FBp707. Precul-
tures were grown overnight in SD-URA or SD-URA-LEU, inoculated 
into YPD medium, and grown for 6–7 h, after which part of the cul-
ture was treated with 200 nM rapamycin (Sigma-Aldrich). After 1 h, 
samples of treated and untreated cells were pelleted at 4°C and 
stored at −80°C. Cell pellets were resuspended in breaking buffer 
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quantification was performed by fluorescence measurements (exci-
tation, 535 nm; emission, 595 nm), normalized for cell number by 
measuring OD595, using a Beckman DTX880 plate reader (Molecular 
Devices, Wokingham, UK).
Reproducibility of results
All experiments were performed at least three times with similar re-
sults. Where applicable, quantification was performed, and results 
are shown as mean values ± SD (shown as error bars). For other ex-
periments, representative results are shown.
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Table S1: Strains used in this study. 
Name   Genotype and markers    Reference 
W303-1A (WT)  MATa ade2-1 can1-100 his3-11,15 leu2-3,112   (Thomas and Rothstein, 1989)
    trp1-1 ura3-1 
JW 00 145  MATα ade2-1 can1-100 his3-11,15 leu2-3,112   (Thomas and Rothstein, 1989) 
trp1-1 ura3-1        
BS_188   W303-1A TRP1+      This study 
JW 00 035  W303-1A with sch9::TRP1     (Roosen et al., 2005) 
JW 01 418   W303-1A with sch9::NATMX4    This study 
BY4741 (WT)   MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0   Y.K.O. Collection 
BY4742   MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0   Y.K.O. Collection 
JW 01 306   BY4741 with sch9::HIS3     (Swinnen et al., 2005) 
JW 03 038   BY4741 with sch9::NATMX4     This study 
isc1Δ    BY4741 with isc1::KANMX4     Y.K.O. Collection 
sur2Δ    BY4742 with sur2::KANMX4     Y.K.O. Collection 
lcb4Δ   BY4742 with lcb4::KANMX4     Y.K.O. Collection 
lcb5Δ    BY4742 with lcb5::KANMX4     Y.K.O. Collection 
lcb3Δ   BY4742 with lcb3::KANMX4    Y.K.O. Collection 
ysr3Δ    BY4742 with ysr3::KANMX4     Y.K.O. Collection 
lag1Δ    BY4742 with lag1::KANMX4     Y.K.O. Collection 
lac1Δ   BY4742 with lac1::KANMX4     Y.K.O. Collection 
sur4Δ    BY4742 with sur4::KANMX4     Y.K.O. Collection 
ydc1Δ   BY4742 with ydc1::KANMX4     Y.K.O. Collection 
ypc1Δ    BY4742 with ypc1::KANMX4     Y.K.O. Collection 
csg2Δ    BY4742 with csg2::KANMX4     Y.K.O. Collection 
sur1Δ    BY4742 with sur1::KANMX4     Y.K.O. Collection 
ipt1Δ    BY4742 with ipt1::KANMX4     Y.K.O. Collection 
isc1Δ   BY4742 with isc1::KANMX4     Y.K.O. Collection 
svf1Δ    BY4742 with svf1::KANMX4     Y.K.O. Collection 
sch9Δ sur2Δ  BY with sch9::HIS3 sur2::KANMX4   This study(1) 
sch9Δ lcb4Δ  BY with sch9::HIS3 lcb4::KANMX4   This study(1) 
sch9Δ lcb5Δ  BY with sch9::HIS3 lcb5::KANMX4   This study(1) 
sch9Δ lcb4Δ lcb5Δ BY with sch9::HIS3 lcb4::KANMX4 lcb5::KANMX4 This study(1) 
sch9Δ lcb3Δ  BY with sch9::HIS3 lcb3::KANMX4   This study(1) 
sch9Δ ysr3Δ  BY with sch9::HIS3 ysr3::KANMX4   This study(1) 
sch9Δ lcb3Δ ysr3Δ BY with sch9::HIS3 lcb3::KANMX4 ysr3::KANMX4 This study(1) 
sch9Δ lac1Δ  BY with sch9::HIS3 lac1::KANMX4   This study(1) 
sch9Δ lag1Δ  BY with sch9::HIS3 lag1::KANMX4   This study(1) 
sch9Δ sur4Δ  BY with sch9::HIS3 sur4::KANMX4   This study(1) 
sch9Δ ydc1Δ  BY with sch9::HIS3 ydc1::KANMX4   This study(1) 
sch9Δ ypc1Δ  BY with sch9::HIS3 ypc1::KANMX4   This study(1) 
sch9Δ csg2Δ  BY with sch9::HIS3 csg2::KANMX4   This study(1) 
sch9Δ sur1Δ  BY with sch9::HIS3 sur1::KANMX4   This study(1) 
sch9Δ ipt1Δ  BY with sch9::HIS3 ipt1::KANMX4   This study(1) 
sch9Δ isc1Δ  BY with sch9::HIS3 isc1::KANMX4   This study(1) 
sch9Δ svf1Δ  BY with sch9::HIS3 svf1::KANMX4   This study(1) 
JW 04 601  BY4741 with C-terminal 9MYC tagged LAG1  This study (2) 
JW 04 602  JW 03 038 with C-terminal 9MYC tagged LAG1 This study (2) 
JW 04 603  BY4741 with C-terminal 9MYC tagged LAC1  This study (2) 
JW 04 604  JW 03 038 with C-terminal 9MYC tagged LAC1 This study (2) 
JW 04 606  BY4741 with C-terminal 9MYC tagged ISC1  This study (2) 
JW 04 607  JW 03 038 with C-terminal 9MYC tagged ISC1  This study (2) 
JW 04 610  BY4741 with C-terminal 9MYC tagged YDC1  This study (2) 
JW 04 612  JW 03 038 with C-terminal 9MYC tagged YDC1 This study (2) 
JW 04 613  BY4741 with C-terminal 9MYC tagged YPC1  This study (2) 
JW 04 615  JW 03 038 with C-terminal 9MYC tagged YPC1 This study (2) 
 
(1) Strains were created by crossing JW 01 306 (BY4741 with sch9::HIS3) with BY4742 strains containing the desired 
KANMX4 deletions, followed by sporulation and tetrad dissection. Triple deletion strains were made using appropriate single 
and double deletion strains for crossing and sporulation.  
(2) For C-terminal 9Myc tagging, the Euroscarf plasmid pYM20 (9Myc tag, hphNT1 marker) was used as a template for PCR 
using primers containing 60bp overlap with the region directly before and after the stop codon of the target gene, as described 
in (Janke et al., 2004). Transformants were selected on hygromycin B containing medium and checked with colony PCR for 
correct integration of the 9Myc tag. 
 
Table S2: Plasmids used in this study. 
Name  backbone insert    marker Reference 
 
FBp87  Yeplac195 pSCH9pr-SCH9   URA3  (Reinders et al., 1998) 
pCUP-LAG1 pYEX 4T-1 pCUP1pr-GST-LAG1  URA3  (Martzen et al., 1999) 
pCUP-LAC1 pYEX 4T-1 pCUP1pr-GST-LAG1  URA3  (Martzen et al., 1999) 
FBp431 pYES2  ISC1-GFPuv   URA3  (Vaena de Avalos et al., 2004) 
FBp459 pHS12  pADHpr-preCox4-mCherry LEU2   Addgene 25444 (Benjamin Glick)  
FBp701 YEp357 LAG1 promoter (-780/+30) URA3  this study 
FBp702 YEp357 LAC1 promoter (-750/+18) URA3  this study 
FBp703 YEp357 YDC1 promoter (-750/+30) URA3  this study 
FBp704 YEp357 YPC1 promoter (-750/+30) URA3  this study 
FBp705 pRS415 pSCH9pr-SCH9   LEU2  this study 
FBp706 pRS415 pSCH9pr-SCH95A   LEU2  this study 
FBp707 pRS415 pSCH9pr-SCH92D3E  LEU2  this study 
FBp708 pRS426 pISC1pr-ISC1-GFPuv  URA3  this study 
FBp709 pYX242 KAR2(1Æ135)-mCherry-HDEL LEU2  this study 
 
Table S3: Primers used in this study. 
Name  sequence  
 
LAG1-lacZFw CCGGGATCCGATCTGTTGCCTTCAACAGTGCATTCC  (bp -780 Æ -754, BamHI) 
LAG1-lacZRv CCGGTCGACATCGATAGATTTGTCCGTAGCTGATGTC  (bp 30 Æ 3, SalI) 
LAC1-lacZFw CCGGGATCCTTTCTGTCGCTCTTATGATCCGTTGG  (bp -750 Æ -725, BamHI) 
LAC1-lacZRv CCGGTCGACTGGCTTTATTGTGGACATAGCTCTTGTTTATTGATACTGTG 
    (bp 18 Æ -21, (bp6 mutated (CÆG) to remove endogenous SalI site), SalI) 
YDC1-lacZFw CCGGGATCCCACGGACAGGATTAAGAGTGATCC  (bp -750 Æ -727, BamHI) 
YDC1-lacZRv CCGGTCGACGGCTTCTGGATAAGGCCAGCTGAACAGC  (bp 30 Æ 3, SalI) 
YPC1-lacZFw CCGGGATCCTGCGTAGTGTGAGTGCCACTAG (bp -750 Æ -729, BamHI) 
YPC1-lacZRv CCGGTCGACCTCTGGATAGTTCCAACGAAATATTCCC  (bp 30 Æ 3, SalI) 
ISC1-fus1 ccgggccccccctcgaggtcgacggtatcgataagcttgatatcgGCCGCGAGGTCGCCCTGGACGG ( ISC1: 
bp -795 Æ - 774) 
ISC1-RVC GAGTCTTTCTTTACGGTGTTTGG (ISC1: bp 180 Æ 158)  
ISC1-fus5 ATGTACAACAGAAAAGACAGAGATG (ISC1: bp 1 Æ 25) 
ISC1-fus4 gcggtggcggccgctctagaactagtggatcccccgggctgcaggGCAAATTAAAGCCTTCGAGCG 
(CYC1ter: bp 248 Æ 229) 
KAR2-F1 gaattcaccatggatcctagggcccacaagcttacgcgtcgacccgggATGTTTTTCAACAGACTAAGCGC 
(KAR2: bp 1 Æ 23) 
KAR2-F2 gaactccttgatgatggccatgttatcctcctcgcccttgctcacATCATCGGCACCTCTAACTAAAAC  
(KAR2: bp 135 Æ 112) 
mCherry-F1 aattctttccactcctccaatgttttagttagaggtgccgatgatGTGAGCAAGGGCGAGGAGG  
(mCherry 4 Æ 22) 
mCherry-F2  ggaaaaacgttcattgttccttattcagttagctagctgagctcgagatatctcagagctcatcgtg 
CTTGTACAGCTCGTCCATGC (mCherry: bp 705 Æ 686) 
 
 
 SUPPLEMENTARY FIGURES 
 
Figure S1: Genetic interaction of SCH9 with enzymes involved in sphingolipid metabolism.  
(A) Serial dilutions of exponential growing wild type, single, double and triple deletion strains on YPD medium 
with or without the addition of 0.5 μg/ml myriocin. The wild type and the single and double deletion mutants 
with a BY background are segregants from a diploid strain, created by crossing the sch9Δ (JW 01 306; 
background BY4741) strain with the respective single deletion strains with background BY4742. Triple 
deletions are segregants from a diploid strain, created by crossing a double deletion mutant with the single 
deletion mutant carrying the third deletion. (B) Additional deletion of SUR4 or ISC1 in the sch9Δ strain increases 
myriocin resistance. Double deletion strains were spotted directly below the sch9Δ strain, to better observe the 
increase in myriocin resistance. (C) Synthetic sick phenotype of a sch9Δ sur4Δ strain. Diploid cells, 
heterozygous for SCH9 and SUR4 were sporulated, and tetrads were dissected on YPD (in horizontal rows). 
Genotypes are indicated. (D) Overexpression of the ceramide synthases LAG1 or LAC1 suppresses the myriocin 
resistance of the sch9Δ strain. Spottest on SD-URA with or without addition of myriocin of the WT (BY4741) 
and the sch9Δ strain (JW 03 038) transformed with plasmids with Cu2+ inducible over-expression of LAC1 and 
LAG1 (Martzen et al., 1999) or an empty vector (ev).  
 
 
Figure S2: Deletion of SCH9 or rapamycin treatment of cells does not affect Isc1 protein levels. 
The gene encoding the inositol phosphosphingolipid phospholipase C (ISC1) was genomically tagged with a 
9Myc tag in both WT BY4741 and sch9Δ  (JW 03 038) strains. Overnight precultures were inoculated at an 
initial OD600 of 0.3 and grown to OD600 2.0, after which a sample was withdrawn for protein extraction (noted 
as -). The remainder of the culture was treated with 200nM rapamycin and grown for an additional hour, after 
which a second sample for protein extraction was taken (noted as +). After TCA protein extraction, equal protein 
amounts were run on a SDS-PAGE. The tagged enzyme was detected using an anti-Myc antibody, the yeast 
Adh2 serves as an internal control. A representative result for the western blot is shown in (A). Signals for Myc 
detection were quantified and normalized for Adh2 levels. Average results of two independent cultures are 
shown in (B), with standard deviations noted as error bars. 
 
 
Figure S3: Mitochondrial translocation of Isc1 on galactose medium is impaired in the absence of Sch9.  
Wild type (BY4741) and sch9∆ (JW 01 306) expressing Isc1-GFP (from a galactose-inducible promoter, plasmid 
FBp431) and a red fluorescent mitochondrial marker protein (plasmid FBp459, containing fluorescent mCherry 
targeted to the mitochondria by the Cox4 presequence) were grown in YPGAL medium and localization was 
analyzed at the early exponential and post-diauxic growth phase using fluorescence microscopy. Bright field, 
single channel and the corresponding merge are shown for both growth phases. Representative pictures are 
shown. 
 
 Figure S4: Sch9 and Isc1 modulate apoptotic cell death. 
Tests for cell death markers of apoptosis and necrosis (Annexin/PI co-staining) were performed as described by 
(Buttner et al., 2008). The wild type (BY4741), sch9Δ (JW 01 306), isc1Δ and sch9Δisc1Δ strains were 
inoculated in fresh synthetic complete medium at an OD600 0,1. After 12h (exponential phase) and 36h (post-
diauxic phase) cells were stained using Annexin-V-FITC and propidium iodide (PI), to detect phosphatidyl 
serine externalization and loss of membrane integrity, respectively, as described by (Buttner et al., 2008). 
Quantitative flow cytometric analysis, using a BD influx flow cytometer, on the apoptotic/necrotic markers was 
performed and analysis was carried out using FlowJo software. Results depicted are mean values ± SD of three 
independent cultures.  
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